Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug
Tohoku University Hospital, Japan
Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!
UK Launches First Clinical Trial Of Proton Beam Therapy For Breast Cancer To Help Patients Reduce The Risk Of Heart Problems Caused By Radiotherapy
Why Is Astrazeneca Willing To Spend a Whopping $12.1 Billion?
Are colds caused by being too cold
